CMEs and Educational Opportunities available

Learn more about our upcoming symposiums

For Health Care Professionals

Karmanos Cancer Institute is the only hospital in Michigan focused solely on cancer. That means we're completely devoted to offering every patient the best treatment options. From groundbreaking original research to offering the most up-to-date treatment options, Karmanos' experts offer tomorrow's standard of care today. 

We believe that patients, referring physicians, and the Karmanos Cancer Institute staff are all critical members of the treatment team. We are committed to proactive, candid, timely communication so everyone knows where their case stands and is prepared to participate in meaningful ways. Superior communication means everyone can do their job better. Learn more about how we guide our patients through the health care system with Cancer Care Navigators.

Power of the Karmanos Advantage

The Latest From Karmanos Cancer Institute

News

Karmanos, WSU Faculty Members Selected by Michigan Cancer Consortium to Support Statewide Cancer Control Efforts

The Michigan Cancer Consortium (MCC) has selected two Barbara Ann Karmanos Cancer Institute researchers and Wayne State University School of Medic...

Read More

Abstracts Now Accepted for 3rd Annual Science of Community Outreach and Engagement Conference, Co-Hosted by Karmanos, WSU

Abstracts are now being accepted for the Science of Community Outreach and Engagement Conference (SoCOE), which will be held May 6-8 at the Cambri...

Read More

Karmanos Cancer Institute Receives the 2026 Women’s Choice Award® as One of America’s Best Hospitals for Cancer Care

Karmanos Cancer Hospital, part of the Barbara Ann Karmanos Cancer Institute , has been named one of America’s Best Hospitals for Cancer Care in 20...

Read More
News

WDET | Doctor Says HPV Vaccine and Routine Screenings Aid Against Cervical Cancer

Listen Now

WWJ | World Cancer Day

Listen Now

WWJ | Ribbon Cutting Held for New Karmanos Cancer Center in Dearborn That Strives to Improve Access to Treatment, Clinical Trials

Listen Now